A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

Status:
Terminated

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

This is a safety and efficacy study of AGN-214868 in patients with postherpetic neuralgia (PHN).

Phase 2

Allergan